Characteristics and treatment of coagulopathy associated with COVID-19
Coagulopathy in COVID-19 represents a thrombo-inflammatory condition, and it is one of the most important causes of morbidity and mortality in this disease. The occurrence of coagulopathy correlates with the intensity of the inflammatory response to SARS-Cov-2 virus infection, and its presence is ch...
Guardado en:
Autor principal: | Miljić Predrag |
---|---|
Formato: | article |
Lenguaje: | EN SR |
Publicado: |
University of Belgrade, Medical Faculty
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9ab2cc8885294d1188a210c3e77f2fed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COVID-19 Associated Coagulopathy and Implications for its Treatment
por: Cherneva Zh., et al.
Publicado: (2020) -
COVID-19-associated coagulopathy in children and adolescents
por: M. V. Gomellya, et al.
Publicado: (2021) -
Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in Japan
por: Seiya Oba, et al.
Publicado: (2021) -
Diagnostic and prognostic value of Sepsis-Induced coagulopathy and International Society on Thrombosis and Hemostasis scoring systems in COVID-19-associated disseminated intravascular coagulopathy
por: Sayyideh Forough Hosseini, et al.
Publicado: (2021) -
Anticoagulation is the answer in treating noncritical COVID-19 patients
por: Kabir Azad A.
Publicado: (2021)